JP2001526217A - 血管性頭痛に対する局所麻酔薬の新規な使用 - Google Patents

血管性頭痛に対する局所麻酔薬の新規な使用

Info

Publication number
JP2001526217A
JP2001526217A JP2000525094A JP2000525094A JP2001526217A JP 2001526217 A JP2001526217 A JP 2001526217A JP 2000525094 A JP2000525094 A JP 2000525094A JP 2000525094 A JP2000525094 A JP 2000525094A JP 2001526217 A JP2001526217 A JP 2001526217A
Authority
JP
Japan
Prior art keywords
ethyl
amine
phenoxy
propoxy
isopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000525094A
Other languages
English (en)
Japanese (ja)
Inventor
カール−ヨーハン・ダールスガード
アーネ・エーク
レンナート・ヴァルデンリンド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2001526217A publication Critical patent/JP2001526217A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2000525094A 1997-12-19 1998-12-14 血管性頭痛に対する局所麻酔薬の新規な使用 Pending JP2001526217A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (sv) 1997-12-19 1997-12-19 New use
SE9704770-8 1997-12-19
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
JP2001526217A true JP2001526217A (ja) 2001-12-18

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000525094A Pending JP2001526217A (ja) 1997-12-19 1998-12-14 血管性頭痛に対する局所麻酔薬の新規な使用

Country Status (18)

Country Link
EP (1) EP1047412A1 (sv)
JP (1) JP2001526217A (sv)
KR (1) KR20010024768A (sv)
CN (1) CN1282241A (sv)
AU (1) AU1898199A (sv)
BR (1) BR9813775A (sv)
CA (1) CA2314452A1 (sv)
EE (1) EE200000394A (sv)
HU (1) HUP0100599A3 (sv)
ID (1) ID26703A (sv)
IL (1) IL136518A0 (sv)
IS (1) IS5534A (sv)
NO (1) NO20003138L (sv)
PL (1) PL341283A1 (sv)
SE (1) SE9704770D0 (sv)
SK (1) SK7832000A3 (sv)
TR (1) TR200001926T2 (sv)
WO (1) WO1999032103A1 (sv)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018532728A (ja) * 2015-09-24 2018-11-08 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー （持続性）外傷後頭痛の予防、治療および低減
US11028160B2 (en) 2016-09-23 2021-06-08 Teva Pharmaceuticals International Gmbh Treating refractory migraine
US11555064B2 (en) 2014-03-21 2023-01-17 Teva Pharmaceuticals International Gmbh Treating headache comprising administering an antibody to calcitonin gene-related peptide

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2862200A (en) 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11555064B2 (en) 2014-03-21 2023-01-17 Teva Pharmaceuticals International Gmbh Treating headache comprising administering an antibody to calcitonin gene-related peptide
JP2018532728A (ja) * 2015-09-24 2018-11-08 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー （持続性）外傷後頭痛の予防、治療および低減
JP2020002172A (ja) * 2015-09-24 2020-01-09 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー （持続性）外傷後頭痛の予防、治療および低減
US11028160B2 (en) 2016-09-23 2021-06-08 Teva Pharmaceuticals International Gmbh Treating refractory migraine
US11028161B2 (en) 2016-09-23 2021-06-08 Teva Pharmaceuticals International Gmbh Treating refractory migraine

Also Published As

Publication number Publication date
CA2314452A1 (en) 1999-07-01
SE9704770D0 (sv) 1997-12-19
ID26703A (id) 2001-02-01
BR9813775A (pt) 2000-10-10
CN1282241A (zh) 2001-01-31
HUP0100599A2 (hu) 2002-02-28
NO20003138L (no) 2000-08-18
IL136518A0 (en) 2001-06-14
PL341283A1 (en) 2001-04-09
EE200000394A (et) 2001-12-17
KR20010024768A (ko) 2001-03-26
NO20003138D0 (no) 2000-06-16
HUP0100599A3 (en) 2002-04-29
TR200001926T2 (tr) 2000-11-21
SK7832000A3 (en) 2001-02-12
AU1898199A (en) 1999-07-12
IS5534A (is) 2000-06-15
EP1047412A1 (en) 2000-11-02
WO1999032103A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
EP0506658B1 (en) Compositions and method for treating painful, inflammatory or allergic disorders
EP0481675A2 (en) Preparation of medicaments for treating asthma using (S)-alpha-fluoromethyl histidine and esters thereof
KR20040049849A (ko) 감기 치료용 조성물
WO2002022128A1 (en) A method of local anesthesia and analgesia
JP2003521462A (ja) 男性における器質性勃起機能不全治療のための医薬品製造におけるアポモルヒネの使用
JP2003176240A (ja) ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法
EP2152232A1 (en) Methods and compositions for administration of oxybutynin
JP2002534477A (ja) メラガトランの新規使用
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
JP2003511410A (ja) 肥満症の治療のためのモルホリノール誘導体
JP4306837B2 (ja) スクラルファート含有局所投与用医薬組成物
JPH0149124B2 (sv)
US7074834B2 (en) Long acting, reversible veterinary sedative and analgesic and method of use
JPH061721A (ja) 疼痛処置剤、及び疼痛軽減作用増強剤
US11642328B2 (en) Creatine, its derivatives, compositions and methods of use thereof
WO2017211182A1 (zh) 一种预防或治疗炎性疾病的药物组合物
KR20090103656A (ko) 섬유근육통 치료제
MXPA00005861A (en) New use of local anaesthetics against vascular headaches
CZ20002254A3 (cs) Nové použití lokálních anestetik proti vaskulárním bolestem hlavy
CN117243948A (zh) 包含瑞香素的组合物在制备风湿性关节炎药物中的应用
JP2003522792A (ja) 薬剤調製用化合物の用途
WO2001035946A2 (en) Intranasal administration of raloxifene and tamoxifen
JPS60208907A (ja) 毛髪成長刺激剤
EP1214073A2 (en) Use of dexrazoxane for treating psoriasis